Bio-Techne Corp (TECH) Covered Calls

Bio-Techne Corporation is a global life sciences company that develops and manufactures high-quality purified proteins and reagent solutions. The company provides a wide range of products including cytokines, antibodies, small molecules, and ELISAs for the research and clinical diagnostic markets. Operating through its Protein Sciences and Diagnostics and Genomics segments, Bio-Techne serves the pharmaceutical, biotechnology, academic, and diagnostic testing communities worldwide.

You can sell covered calls on Bio-Techne Corp to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TECH (prices last updated Thu 4:16 PM ET):

Want to make money with covered calls?  Sign Up For A Free Trial

Bio-Techne Corporation is a leading provider of life science reagents, instruments, and services that empower researchers and clinicians to achieve reproducible and consistent results. Headquartered in Minneapolis, Minnesota, the company has grown through strategic acquisitions of specialized brands such as R&D Systems, ProteinSimple, and Lunaphore. Bio-Techne is recognized for its extensive catalog of high-quality biological materials, particularly in the fields of protein science and spatial biology.

Core Business and Products

The company operates through two primary segments. The Protein Sciences segment offers purified proteins, antibodies, and small molecules alongside automated protein analysis systems like the Simple Western platform. The Diagnostics and Genomics segment focuses on molecular diagnostics, clinical quality controls, and advanced spatial genomics technology. Together, these divisions support the entire drug discovery and development lifecycle—from basic academic research to commercial-scale therapeutic production and patient diagnostic testing.

Competitive Landscape

The life sciences tools and services market is highly specialized, requiring significant investment in research and development. Bio-Techne competes with large-scale global laboratory providers and specialized biotechnology firms based on product purity, reliability, and technological innovation. Key publicly traded, optionable competitors include:

1. Danaher Corporation: A global science and technology innovator that competes through its extensive portfolio of life sciences and diagnostic platforms.
2. Thermo Fisher Scientific: The world leader in serving science, providing a vast range of laboratory equipment and reagents that compete across all of Bio-Techne’s market segments.
3. Agilent Technologies: A leader in life sciences, diagnostics, and applied chemical markets, competing in analytical instrumentation and clinical research solutions.
4. Bio-Rad Laboratories: This company develops and manufactures a broad range of products for the life science research and clinical diagnostics markets, directly competing in reagent and instrument sales.
5. Revvity, Inc.: A specialized provider of health science solutions that competes in the areas of diagnostics, life science research, and high-performance laboratory services.

Strategic Outlook and Innovation

Bio-Techne is heavily invested in the "spatial biology" revolution, developing integrated platforms that allow scientists to visualize protein and gene expression within the context of tissue architecture. By expanding its COMET™ suite and other modular imaging tools, the company aims to become a standard-setter for complex oncology and neuroscience research. Innovation efforts also extend to the development of next-generation cytokines and growth factors required for the burgeoning cell and gene therapy markets.

Management is focused on maintaining industry-leading margins through high-value consumables and the successful integration of its recent acquisitions. The company’s long-term strategy involves leveraging its brand reputation for quality to expand its footprint in high-growth international markets, particularly in the China/APAC region. By balancing its core reagent business with higher-growth instrument and diagnostic platforms, Bio-Techne intends to deliver consistent value to its shareholders while advancing the global medical community's understanding of human biology.

Want more examples? TECB Covered Calls | TECK Covered Calls